Cargando…
Promising drugs and treatment options for pediatric and adolescent patients with Hodgkin lymphoma
Currently-available therapies for newly-diagnosed pediatric and adolescent patients with Hodgkin lymphoma result in >95% survival at 5 years. Long-term survivors may suffer from long-term treatment-related side effects, however, so the past 20 years have seen clinical trials for children and adol...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9729954/ https://www.ncbi.nlm.nih.gov/pubmed/36506094 http://dx.doi.org/10.3389/fcell.2022.965803 |